Streetbeat News

Stock Prices

UNCY

Unicycive Therapeutics Inc has received a notice from Nasdaq stating that the company is not in compliance with the $1.00 minimum bid price requirement, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2023 | 8:23 pm

AMZN

MSFT

SPY

The S&P 500 index saw modest gains on Monday, breaking a four-session losing streak. The index is recovering from its second-worst week of the year, with a 2.9% decline. Among the top 10 components of the S&P 500 index, nine stocks recorded gains, with Microsoft being the exception. Amazon provided the most substantial boost to the market’s daily performance with a 1.6% increase. However, a surge in Treasury yields somewhat restrained the bullish sentiment. The S&P 500 has experienced a 6% decline since its peak in July, with a critical level to monitor being 4,200, which could signal a major trend reversal for the broader market.

Portfolio Pulse from Piero Cingari

September 25, 2023 | 8:22 pm

THO

Thor Industries has projected its FY24 consolidated net sales to be between $10.5B and $11.0B, with an estimated EPS of $6.25-$7.25. The company also anticipates a consolidated gross profit margin in the range of 14.5% to 15.0%.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2023 | 8:19 pm

VAPO

Vapotherm Inc (NASDAQ:VAPO) announced the results of a clinical trial showing its high flow humidified oxygen therapy to be more effective than standard oxygen therapy in treating children with acute severe asthma. The study found that fewer children treated with Vapotherm's therapy required escalation of treatment and met hospital discharge criteria sooner. Despite the positive trial results, VAPO shares are down 3.85%.

Portfolio Pulse from Vandana Singh

September 25, 2023 | 8:16 pm

SHW

Sherwin-Williams Inc.'s (NYSE:SHW) share price increased by 0.60% in the current market session to $256.21. Despite a 5.27% decrease over the past month, the stock has risen by 22.85% over the past year. The company's P/E ratio of 28.27 is lower than the Chemicals industry average of 36.56, which could indicate that the stock is undervalued or has weaker growth prospects.

Portfolio Pulse from Benzinga Insights

September 25, 2023 | 8:15 pm

BTCUSD

MSTR

Jordan Belfort, known as The Wolf of Wall Street, has revised his previous stance on cryptocurrency, now believing that Bitcoin has lasting power. He maintains that the majority of cryptocurrencies are scams, but admits he was wrong about Bitcoin and Ethereum. Belfort also praised MicroStrategy Inc's co-founder and executive chairman Michael Saylor's understanding of Bitcoin.

Portfolio Pulse from Chris Katje

September 25, 2023 | 8:11 pm

COTY

Coty Inc has filed for a stock shelf offering, the size of which has not been disclosed. The company has also submitted an application to dual-list its Class A common stock on the professional segment of the regulated market of Euronext Paris. However, it does not intend to list its preferred stock on any exchange, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2023 | 8:10 pm

BEBE

RILY

B. Riley is set to increase its total holdings of bebe to approximately 76% by acquiring 3.7 million common shares from founder Manny Mashouf at $5.00 per share, totaling $18.5 million.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2023 | 8:03 pm

DE

A significant amount of unusual options activity has been observed for Deere (NYSE:DE), indicating a bullish stance by a large investor or institution. The overall sentiment among these big-money traders is split between 56% bullish and 43% bearish. The targeted price range for Deere over the last 3 months has been $370.0 to $440.0. Deere's current price is up 0.91% at $384.33. Analysts from Canaccord Genuity, HSBC, and Evercore ISI Group have recently downgraded their ratings for Deere.

Portfolio Pulse from Benzinga Insights

September 25, 2023 | 8:02 pm

VRTX

A significant bearish stance has been taken on Vertex Pharmaceuticals (NASDAQ:VRTX) by a large investor, as indicated by unusual options trades. The sentiment among these big-money traders is 27% bullish and 72% bearish. The whales have been targeting a price range from $340.0 to $370.0 for Vertex Pharmaceuticals over the last 3 months. Cantor Fitzgerald has downgraded its action to Overweight with a price target of $370.

Portfolio Pulse from Benzinga Insights

September 25, 2023 | 8:01 pm